Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function
about
The potential of antimicrobials to induce thrombocytopenia in critically ill patients: data from a randomized controlled trialHow do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?Absorption of ciprofloxacin in patients with diabetic gastroparesis.Penetration of ciprofloxacin and fleroxacin into biliary tract.Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulationPharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.Steady-state pharmacokinetics of intravenous and oral ciprofloxacin in elderly patients.Relationships between renal function and disposition of oral ciprofloxacinIn vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic studyFluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters.Pharmacokinetics of ciprofloxacin with reference to other fluorinated quinolones.Influence of renal failure on intestinal clearance of ciprofloxacin in rats.Influence of renal failure on ciprofloxacin pharmacokinetics in rats.Treatment of gram-negative infections in patients with renal impairment: new alternatives to aminoglycosides.Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients.Peroral treatment with ciprofloxacin of patients with spinal cord lesion and bacteriuria caused by multiply resistant bacteria.Pharmacokinetic interaction of ketoconazole and itraconazole with ciprofloxacin.Timing, dosing and duration of antimicrobial prophylaxis in urology: a study in guinea pigs with special reference to high-risk conditions.
P2860
Q28535471-284A0766-7B61-44AB-80F0-F93876F62C12Q34894900-B63A56B3-F2D5-42A3-AB56-E97655EB6E97Q35118948-AEDA34DF-6C27-44C3-9317-DDBA38B2287EQ35123362-BDA9A268-4EB1-4DE1-B702-EAA8011367D3Q35210471-E44D6987-E2FB-415E-92F4-287C0934F279Q35245010-894642B8-54CF-4FCE-9366-41CF4619CF65Q35359695-334D779F-A854-426C-84A0-5B8C08C63113Q35564482-C809D3FD-6351-42FC-8C4D-016BDB0D9B56Q35822578-8E446462-9FA5-49A2-9809-8B7E7D14CEB4Q36754888-127E686B-DB28-42B0-86D3-60B44B7FB856Q37995676-4D548820-B3A5-4880-A5A2-AC0C87B5D41CQ38271416-0AFD9663-010B-4AD4-8382-6E9EE4FA8392Q39470347-E863063C-7EB4-4705-959D-585256B8C833Q39556635-6563E05C-816F-4B00-B2EC-5F8C0C7C88FFQ39558431-194DA528-BC22-4B76-B4EB-A334D15B81D6Q39815523-E766E9F3-8D20-47DE-9966-74BC841D2F08Q45208000-3D5F24CF-2C5D-4395-B9C1-E6CD0C45382EQ46944517-B15CEA65-9571-449F-BF3C-4A89813D32DEQ54663958-E597D5F2-104F-401F-B34F-4A10F23067E4
P2860
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function
description
1987 nî lūn-bûn
@nan
1987 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function
@ast
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function
@en
type
label
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function
@ast
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function
@en
prefLabel
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function
@ast
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function
@en
P2093
P2860
P356
P1476
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function
@en
P2093
P2860
P304
P356
10.1128/AAC.31.5.709
P407
P577
1987-05-01T00:00:00Z